PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
August 14, 2025Scientific Reports36 citationsOpen Access

Combined preoperative platelet-albumin ratio and cancer inflammation prognostic index predicts prognosis in colorectal cancer: a retrospective study

View Full Paper
KWKuan WangKLKejin LiZZZiyi Zhang

Key Points

  • Combined use of platelet-albumin ratio and cancer inflammation prognostic index predicts poorer overall survival in colorectal cancer patients.
  • In a study of 434 colorectal cancer patients, high levels of both preoperative markers were independently linked to worse outcomes.
  • Retrospective analysis using ROC curves established optimal cutoff values for the cancer inflammation prognostic index and PAR.
  • Integrated nomogram models demonstrated superior prognostic accuracy, indicating potential for personalized treatment strategies.

Abstract

Colorectal cancer (CRC) has one of the highest incidence and mortality rates of any cancer worldwide, and the recurrence and metastasis rates after surgery remain high. The search for simple and reliable prognostic markers is essential to improve patient prognosis. In this study, we investigated the predictive value of two easy-to-measure preoperative markers, platelet-to-albumin ratio (PAR) and cancer inflammation prognostic index (CIPI), in postoperative survival of patients with CRC. We retrospectively analyzed the clinical data of a total of 434 CRC patients from two hospitals. Data from one of the institutions were used as a training cohort. The predictive ability of both markers was assessed using subject work characteristics (ROC) curves, with optimal cutoff values of 11.69 and 6.85 for CIPI and PAR, respectively, and high CIPI and PAR were independently associated with poorer overall survival. We developed nomogram of overall survival (OS), performed internal and external validation, and showed superior prognostic accuracy of the nomogram models. Our results suggest that combined CIPI and PAR can be used as a valid and accessible prognostic tool that is expected to help develop personalized treatment strategies for CRC patients.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Wang et al. (2025) studied this question.

synapsesocial.com/papers/68a3635e0a429f797332a7c4https://doi.org/10.1038/s41598-025-15309-w
Ask AI
Helpful
Bookmark
Share
View Full Paper